Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Aspects of Healthcare that Have Evolved for Good in the Wake of COVID

Although many people are hoping for things to return to normal after the pandemic is over, the healthcare industry is one area that won’t look the same in a post-pandemic world. In a matter of weeks, the entire industry was upended in an attempt to save the lives of those affected by the coronavirus –…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Aspects of Healthcare that Have Evolved for Good in the Wake of COVID

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Although many people are hoping for things to return to normal after the pandemic is over, the healthcare industry is one area that won’t look the same in a post-pandemic world. In a matter of weeks, the entire industry was upended in an attempt to save the lives of those affected by the coronavirus – and the ripples of these changes will affect the industry for years to come.

Here, we’ll look at three aspects of healthcare that have been transformed by the COVID-19 pandemic.

Trend #1: A Greater Emphasis on Patient-Focused Care

Before the pandemic, receiving care was a process that often took longer than necessary, with administrative bottlenecks and wait times at an all-time high.

However, because of the coronavirus crisis, healthcare leaders are understanding the importance of people receiving care when they need it. After all, any lack in urgency could easily cost someone their life.

The focus on healthcare is slowly transitioning to a patient-focused model, where care and overall service revolves around the care receiver rather than the provider. As a result, features like easily accessible electronic forms and prescription delivery services encourage patients to get more involved with their care and improve their overall experience.

Trend #2: Elevated Telehealth and Remote Patient Monitoring

Not long ago, telehealth was seen as inferior to in-person care and a last resort option for many patients. Nowadays, it’s essential to the health and safety of both patients and care providers.

Because telehealth doctors don’t have the same logistical restraints that in-person providers have, patients can often secure telehealth appointments much sooner. They can also be treated wherever they are without risking infection from others, especially if they’re immunocompromised.

On the other hand, those who do have COVID can be treated while limiting the risk of exposure to those around them.

Trend #3: Increased In-Home Care for the Elderly

Many families feel uneasy about bringing their relatives to a nursing home, in part because of the lack of transparency around the care they receive. However, the pandemic has highlighted another reason to reconsider the idea.

New York Times article revealed that 34% of all American COVID deaths at the time of writing – a staggering 152,000 – were linked to nursing homes. A crowd of people living together in a cramped space makes it easier for diseases to spread, and weakened immune systems result in more deaths.

Although sickness is an inevitable part of life, families are now choosing to reduce the risk by keeping their relatives close to home. Others even have their loved ones move in with them. Additionally, they may decide to hire in-home medical help to ensure that their relatives get the best level of care possible.

Champion: Medical Seating Designed with Evolution in Mind

With the standards of healthcare changing right before our eyes, your patients deserve a level of care that can adapt just as quickly.

Champion has developed medical chairs that can be used in a variety of settings, from acute care, emergent procedures and multipurpose patient needs to in-home treatment. Their versatility allows providers to administer care in a variety of settings, while their user-centric design improves the level of comfort of the patients that use them.

To learn more about Champion’s products and the benefits they offer, visit www.championchair.com/applications.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512